Health
Drug cuts COVID-19 deaths in hospitalized patients by two-thirds: study – Sports Grind Entertainment
An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according…
An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according to a new study.
Called baricitinib, and marketed under the brand name Olumiant, the medication has been touted by its British company as a possible game changer in the fight against COVID-19, the Daily Mail reported.
The rheumatoid arthritis drug, which has been available for only three years, was identified in February as a strong candidate…
-
General8 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News22 hours agoDesign and construction integrity rewarded with national award
-
Noosa News16 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General7 hours agoChina and Philippines trade blame over latest South China Sea clash